TrialInvestigational new drugs2011
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.
Chul Kim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this papertrialcites it